TNF-α

Cat. No.

A10522

CAS No.

191732-72-6

Lenalidomide (CC-5013)

Synonyms: Revlimid; CC-5013

Lenalidomide is a derivative of thalidomide. In vitro, lenalidomide has three main activities: direct anti-tumor effect, inhibition of the micro environment support for tumor cells, and immunomodulatory role. It induces tumor cell apoptosis directly and indirectly by inhibition of bone marrow stromal cell support, by anti-angiogenic and anti-osteoclastogenic effects, and by immunomodulatory activity.

Cat. No.

A23991

CAS No.

1798310-55-0

AR420626

AR420626 is a selective agonist of free fatty acid receptor 3 (FFAR3, also known as GPR41), with an IC₅₀ of 117 nM. It demonstrates anti-inflammatory, antitumor, and antidiabetic activities. AR420626 improves neurogenic diarrhea by modulating neural pathways mediated by nicotinic acetylcholine receptors (nAChRs). In cancer models, it suppresses the growth of HepG2 xenografts and inhibits hepatoma cell proliferation through apoptosis induction. Additionally, AR420626 mitigates allergic asthma and eczema and enhances glucose uptake by activating FFAR3-mediated Ca²⁺ signaling, offering potential therapeutic benefits in metabolic disorders such as diabetes.

Cat. No.

A25239

CAS No.

158983-23-4

VDX-111

VDX-111 is a necroptosis inducer that functions as an analog of vitamin D. It exerts cytotoxic effects in ovarian cancer cells by upregulating the RIPK1/RIPK3 pathway, leading to necroptotic cell death. Additionally, VDX-111 promotes cytokine expression and demonstrates significant antitumor activity in murine models, making it a valuable tool for cancer research focused on necroptosis.

Cat. No.

A25512

CAS No.

18138-19-7

IDT

IDT is a TNFα modulator that targets and regulates the innate immune response. It has demonstrated significant efficacy in reducing paired helical filament tau and fibrillar amyloid accumulation, as well as enhancing the infiltration of neutrophils while decreasing TNFα expression within this population. IDT is a valuable reagent for research focused on Alzheimer’s disease and the underlying mechanisms of neuroinflammation.